• Copper Single-Atom MOFs Enable Ultrasound-Enhanced Cancer Th

  2026-08-06

  This study introduces a copper single-atom-based metal–organic framework (MOF) engineered for ultrasound (US)-activated chemodynamic therapy (CDT) in cancer. The research demonstrates that single-atom Cu sites maximize catalytic efficiency and tumor targeting, with in vivo imaging and therapy validated using a NIR-II fluorescent dye.

• Mitomycin C in Cancer Research: Mechanistic Insights and Evo

  2026-08-06

  Explore the multifaceted role of Mitomycin C as an antitumor antibiotic, with a focus on its advanced applications in apoptosis signaling and cancer research. This article offers a unique, mechanism-centered perspective—distinct from standard protocols—grounding assay choices in the latest molecular insights.

• Ruxolitinib (INCB018424): Reliable Solutions for JAK-STAT As

  2026-08-05

  This scenario-driven guide addresses common laboratory challenges in JAK-STAT pathway and myeloproliferative disorder research, demonstrating how Ruxolitinib (INCB018424) (SKU A3012) from APExBIO delivers reproducible, quantitative results. Evidence-backed Q&A blocks clarify protocol design, data interpretation, and product selection for rigorous cell-based assays.

• Parathyroid hormone (1-34) (human): New Insights into Valvul

  2026-08-05

  Uncover the multifaceted role of Parathyroid hormone (1-34) (human) in valvular calcification and bone metabolism research. This in-depth analysis integrates molecular mechanisms, recent breakthroughs, and practical assay guidance for advanced experimental models.

• Maximizing NIR-II Fluorescence: Rational Liposome Design wit

  2026-08-04

  The referenced study presents a systematic approach to optimizing near-infrared II (NIR-II) fluorescent nanosystems by tailoring the encapsulation of IR-1061 in liposomes of varying charge. Key findings clarify how liposome surface charge and dye aggregation state dictate fluorescence intensity and in vivo imaging performance, providing actionable insights for designing high-performance optical probes in biomedical research.

• Pentoxifylline as an ICAM-1 Modulator: A Paradigm in Inflamm

  2026-08-04

  Explore how Pentoxifylline, a leading phosphodiesterase inhibitor, uniquely downregulates ICAM-1 in monocytes and advances anti-inflammatory research. This article reveals novel mechanistic insights and practical guidance for immunology workflows.

• Amplex Red: Precision in Reactive Oxygen Species Detection A

  2026-08-03

  Amplex Red (10-Acetyl-3,7-dihydroxyphenoxazine) offers unmatched sensitivity for hydrogen peroxide and peroxidase detection in biochemical and cell-based workflows. This guide reveals how APExBIO’s reagent enables robust oxidative stress monitoring, highlights workflow optimizations, and translates new insights from ecosystem redox research into practical assay improvements.

• Genistein: Cytoskeleton-Dependent Autophagy and Cancer Workf

  2026-08-03

  Genistein's dual role in protein tyrosine kinase inhibition and modulation of cytoskeleton-dependent autophagy enables unrivaled experimental flexibility in cancer and mechanotransduction research. This article translates the latest mechanistic insights into precise, actionable workflows for scientists investigating cell proliferation, apoptosis, and chemoprevention.

• A20 Suppresses Oxidized Self-DNA Inflammation in AKI Models

  2026-08-02

  This study uncovers how the ubiquitin-editing enzyme A20 mitigates inflammation driven by oxidized self-DNA in acute kidney injury (AKI). By delineating the suppression of the NLRP3 inflammasome and cGAS-STING pathway, the research provides mechanistic insights into inflammation control in AKI and highlights new therapeutic strategies.

• Cardiogreen (Indocyanine Green): Translational Leverage in D

  2026-08-01

  This thought-leadership article explores how Cardiogreen (Indocyanine Green) advances both precision diagnostics and immuno-oncology research. Bridging mechanistic insight from tumor biology to practical translational guidance, it highlights Cardiogreen's dual role as a vascular imaging dye and a potent photosensitizer for photodynamic therapy, contextualized within emerging immunotherapy strategies. The discussion critically integrates recent findings on photothermal therapy and tumor microenvironment modulation, offering actionable protocols and strategic recommendations for translational researchers.

• Cy5 amine (non-sulfonated): Technical Guide for Biomolecule

  2026-07-31

  Cy5 amine (non-sulfonated) provides a bright, photostable, amine-functionalized cyanine dye for sensitive labeling of proteins, peptides, and polymers in non-aqueous or mixed-solvent workflows. It is not suitable for direct aqueous labeling or diagnostic/clinical applications, and requires rigorous solvent and protocol control for reproducible fluorescence detection.

• Hydroxychloroquine Sulfate for Autoimmune Disease Research W

  2026-07-31

  Hydroxychloroquine Sulfate (SKU B4874) is designed for research applications targeting autophagy and toll-like receptor signaling in autoimmune disease models. It is optimized for aqueous-based, short-term workflows and is not compatible with protocols requiring organic solvents or long-term solution storage.

• Actinomycin D in Cancer Research: Workflows, Assays & Troubl

  2026-07-30

  Actinomycin D (ActD) delivers precision transcriptional inhibition, enabling robust analysis of mRNA stability, DNA damage response, and apoptosis induction in cancer models. By leveraging validated protocols and troubleshooting strategies, researchers can maximize data fidelity and reproducibility in complex cellular assays.

• GPR35-KLF5 Circuitry Decodes Damage Signals in Colitis Repai

  2026-07-30

  This study uncovers how intestinal epithelial cells use GPR35 to sense tryptophan metabolism perturbations and activate KLF5-driven repair programs via PI3K-AKT-mTOR signaling. The findings provide mechanistic insight into mucosal healing in ulcerative colitis and suggest new strategies for targeted intervention in intestinal inflammation models.

• JNJ-26854165 (Serdemetan): Advanced Insights for p53 Modulat

  2026-07-29

  Explore the unique anti-proliferative and apoptosis-inducing properties of JNJ-26854165 (Serdemetan) in p53 wild-type cancer models. This in-depth analysis reveals new assay strategies and practical considerations for cancer research.

16386 records 1/1093 page Next 12345 下5页 Last page